Novartis AG

In News

Novartis AG (NVS) states Rare Muscle Disease Drug Shows Promise in Early Trial - Yahoo Finance

Yahoo Finance - Jun 23, 2026

Novartis AG Stock (NVS) Closed Up by 3.04% on Jun 23: What Signal Does It Send? - TradingKey

TradingKey - Jun 23, 2026

Curium Knocks Out Novartis Cancer Drug Patents in Generics Fight - Bloomberg Law News

Bloomberg Law News - Jun 18, 2026

Novartis AG (NVS): 7 Best Longevity and Anti-Aging Stocks to Buy - Yahoo Finance

Yahoo Finance - Jun 22, 2026

Novartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its late-stage neuroscience pipeline - Novartis

Novartis - Oct 26, 2025

Novartis says rare muscle disease drug shows promise in early trial - Reuters

Reuters - Jun 11, 2026

Novartis AG (NVS) Stock Analysis: Insights Into Growth Potential And Market Position - DirectorsTalk Interviews

DirectorsTalk Interviews - Jun 22, 2026

Novartis taps Orionis for second molecular glue tie-up: Deals Report - BioCentury

BioCentury - Jun 15, 2026

Case overview: Novartis AG and Genentech v SHARx and Campbell Heights Pharmacy (2026 — ) – ongoing - Partnership for Safe Medicines

Partnership for Safe Medicines - Feb 25, 2026

Novartis AG Falls Monday - Moomoo

Moomoo - Jun 08, 2026

Is Novartis AG (NVS) Overvalued After 3.9% Rally? GF Value Says - GuruFocus

GuruFocus - Jun 12, 2026

Genentech, Novartis Accused of Drug Kickback Schemes in Lawsuit - Bloomberg Law News

Bloomberg Law News - Jun 22, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment